Intravenous lipid emulsion treatment in rabbits with ivermectin toxicosis.

Abstract

To determine the effect and safety of IV lipid emulsion in rabbits with acute ivermectin toxicosis. Randomized controlled trial. University research facility. Twenty-four healthy male adult New Zealand rabbits. Three groups of rabbits (IV, IV_RL, and IV_LE) received 80mg/kg of ivermectin (8mL/kg) through a nasogastric tube, and 1 group (LE) received an equivalent volume (8mL/kg) of 0.9% sodium chloride. Group IV_RL was treated with Ringer's lactate (2mL/kg bolus, followed by 0.25mL/kg/min for 60 minutes), whereas groups IV_LE and LE received 20% lipid emulsion. The rabbits were submitted to clinical and neurological evaluation, and blood samples were collected for biochemical analysis. All animals were euthanized, and tissue samples were collected and processed for histopathological evaluation and ivermectin quantification. All animals exposed to ivermectin manifested clinical changes consistent with toxicosis, but the ones that received IV lipid emulsion infusion showed no significant clinical improvement. Intense increase in serum glucose and triglyceride concentrations was seen after ivermectin exposure, along with increased urea and creatinine concentrations, but the last 2 remained within the reference range. Lipid emulsion caused an intense increase in triglycerides and cholesterol concentrations. No pathological abnormalities were seen in the organs sampled. Toxicological analysis showed greater ivermectin concentration in adipose tissue and liver, followed by kidney and, finally, brain. The treatments did not change ivermectin tissue concentration. When given to rabbits intoxicated with ivermectin, IV lipid emulsion was biochemically and histologically safe but was not effective in treating, delaying, or reversing clinical signs and progression, nor did it alter ivermectin tissue concentration.